Inauguration of Brain Conflux: A New Era of Interdisciplinary Research Bridging Brain Sciences and Clinical Innovation
DOI:
https://doi.org/10.71321/wa1phe43Keywords:
Brain Conflux, Brain Sciences, Clinical InnovationAbstract
As the Editor-in-Chief of Brain Conflux, I am filled with excitement and immense pride as I present this new journal to the global scientific community. Brain Conflux is not just another scientific publication—it is a visionary platform dedicated to advancing the field of neuroscience. With a focus on high-quality research, this peer-reviewed, open-access journal serves as a bridge between fundamental scientific discoveries and their clinical applications, enabling groundbreaking research to translate into meaningful healthcare solutions. In an era where our understanding of the brain is advancing rapidly, the time has come for a unified, interdisciplinary approach to neuroscience. Brain Conflux stands ready to lead this charge, offering an unparalleled platform for collaboration among researchers, clinicians, and policymakers, all working together to solve some of the most urgent challenges in brain health.
References
[1] Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CE, et al. (2021). Alzheimer's disease. Lancet, 397(10284), 1577-1590. https://doi.org/10.1016/s0140-6736(20)32205-4
[2] Ben-Shlomo Y, Darweesh S, Llibre-Guerra J, Marras C, San Luciano M, & Tanner C. (2024). The epidemiology of Parkinson's disease. Lancet, 403(10423), 283-292. https://doi.org/10.1016/s0140-6736(23)01419-8
[3] Feldman EL, Goutman SA, Petri S, Mazzini L, Savelieff MG, Shaw PJ, et al. (2022). Amyotrophic lateral sclerosis. Lancet, 400(10360), 1363-1380. https://doi.org/10.1016/s0140-6736(22)01272-7
[4] Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. (2021). Lancet Neurol, 20(10), 795-820. https://doi.org/10.1016/s1474-4422(21)00252-0
[5] Yozawitz E. (2023). Neonatal Seizures. N Engl J Med, 388(18), 1692-1700. https://doi.org/10.1056/NEJMra2300188
[6] Kanner AM, & Bicchi MM. (2022). Antiseizure Medications for Adults With Epilepsy: A Review. Jama, 327(13), 1269-1281. https://doi.org/10.1001/jama.2022.3880
[7] Lamvu G, Carrillo J, Ouyang C, & Rapkin A. (2021). Chronic Pelvic Pain in Women: A Review. Jama, 325(23), 2381-2391. https://doi.org/10.1001/jama.2021.2631
[8] Schaff LR, & Mellinghoff IK. (2023). Glioblastoma and Other Primary Brain Malignancies in Adults: A Review. Jama, 329(7), 574-587. https://doi.org/10.1001/jama.2023.0023
[9] Global, regional, and national burden of epilepsy, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. (2025). Lancet Public Health, 10(3), e203-e227. https://doi.org/10.1016/s2468-2667(24)00302-5
[10] Ashina M. (2020). Migraine. N Engl J Med, 383(19), 1866-1876. https://doi.org/10.1056/NEJMra1915327
[11] Global, regional, and national burden of stroke and its risk factors, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. (2024). Lancet Neurol, 23(10), 973-1003. https://doi.org/10.1016/s1474-4422(24)00369-7
[12] Haghikia A, Schett G, & Mougiakakos D. (2024). B cell-targeting chimeric antigen receptor T cells as an emerging therapy in neuroimmunological diseases. Lancet Neurol, 23(6), 615-624. https://doi.org/10.1016/s1474-4422(24)00140-6
Type
Published
Data Availability Statement
Not applicable.
Issue
Section
License
Copyright (c) 2025 Brain Conflux
This work is licensed under a Creative Commons Attribution 4.0 International License.
How to Cite
